Evidence map›Paper›PMID 31053993›Full record

ArticleJournal of experimental orthopaedics2019

Association between changes in molecular biomarkers of cartilage matrix turnover and changes in knee articular cartilage: a longitudinal pilot study.

Heide Boeth, Peter C Raffalt, Aoife MacMahon, A Robin Poole, Felix Eckstein, Wolfgang Wirth, Frank Buttgereit, Patrik Önnerfjord, Pilar Lorenzo, Cecilia Klint and 2 more

Abstract read
In one paragraph

Article in Journal of experimental orthopaedics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Heide BoethJulius Wolff Institute, Charité - Universitätsmedizin, Berlin, Germany.
Peter C RaffaltJulius Wolff Institute, Charité - Universitätsmedizin, Berlin, Germany.
Aoife MacMahonJulius Wolff Institute, Charité - Universitätsmedizin, Berlin, Germany.
A Robin PooleDepartment of Surgery, McGill University, Montreal, Quebec, Canada.
Felix EcksteinInstitute of Anatomy, Paracelsus Medical University, Salzburg & Nuremberg, Salzburg, Austria.
Wolfgang WirthInstitute of Anatomy, Paracelsus Medical University, Salzburg & Nuremberg, Salzburg, Austria.
Frank ButtgereitMed. Klinik m. S. Rheumatologie und Klinische Immunologie, Charité - Universitätsmedizin, Berlin, Germany.
Patrik ÖnnerfjordDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Pilar LorenzoDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Cecilia KlintAnaMar AB, Lund, Sweden.
Anna PramhedAnaMar AB, Lund, Sweden.
Georg N DudaJulius Wolff Institute, Charité - Universitätsmedizin, Berlin, Germany. georg.duda@charite.de.

Funding

European Community´s Seventh Framework Program2 NanoDiaRA FP7-NMP4-LA-2009-228929German Federal Ministry of Education and Research BMBF 01EC1408AGerman Research Foundation DU 298/20-1
6 · The paper itself

Abstract

backgroundAn early detection of Osteoarthritis is urgently needed and still not possible until today. The aim of the study was to assess whether molecular biomarkers of cartilage turnover are associated with longitudinal change in knee cartilage thickness during a 2 year period in individuals with increased risk of developing knee osteoarthritis. A secondary aim was to assess whether prior knee injury or subjective patient-reported outcomes at baseline (BL) were associated with articular cartilage changes. Nineteen volleyball players (mean age 46.5 ± 4.9 years, 47% male) with a 30-year history of regular high impact training were recruited. The serum biomarkers Cpropeptide of type II procollagen (CPII), cartilage oligomeric matrix protein (COMP), collagenase generated carboxy-terminal neoepitope of type II collagen (sC2C), cartilage intermediate layer protein 2 (CILP-2), and the urine biomarkers C-telopeptide of type II collagen (CTX-II) and collagenase-generated peptide(s) of type II collagen (C2C-HUSA) were assessed at BL and at 2 year follow up (FU). Femorotibial cartilage thinning, thickening and absolute thickness change between BL and FU was evaluated from magnetic resonance imaging. Subjective clinical status at BL was evaluated by the International Knee Documentation Committee Subjective Knee Form and the Short-Form 36 Physical Component Score.

resultsCILP-2 was significantly higher at FU and linearly associated with the absolute cartilage thickness change during the experimental period. Prior injury was a predictor of increased absolute cartilage thickness change.

conclusionMeasuring the change in the cartilage biomarker CILP-2 might be a valid and sensitive method to detect early development of knee osteoarthritis as CILP-2 appears to be related to cartilage thickness loss in certain individuals with increased risk of developing knee osteoarthritis. Prior knee injury may be predictive of increased articular cartilage thickness change.

Indexed as

AthletesBiomarkersCartilage degradationKnee osteoarthritisVolleyball

Identifiers

PMID31053993
PMCPMC6499840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.